SHANGHAI FOSUN PHARMACEUTICAL (GROUP) CO., LTD.

Insiders Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Hong Kong S.E.

Equities

2196

CNE100001M79

Market Closed - Hong Kong S.E. Other stock markets 09:09:05 07/06/2024 BST			5-day change	1st Jan Change
14.08 ^HKD	+2.18%		+15.03%	-17.18%

06-07	Chinese Regulator Accepts Fosun Pharma Unit's Drug Registration Application for Luvometinib Tablets; Shares Up 3%	MT
06-03	Shanghai Fosun Pharmaceutical Buys Remaining 49% Stake in Nursing Home; Shares Rise 7%	MT

Insiders

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Yuyuan Tourist Mart CFO Steps Down	02-05	MT
ChemPartner PharmaTech CFO Steps Down	09/10/23	MT
Shanghai Fosun Pharmaceutical Co., Ltd. Announces Change of Supervisors	28/06/23	CI
Shanghai Fosun Pharmaceutical Co., Ltd. Announces the Resignation of Cao Genxing as Supervisor	27/03/23	CI
Shanghai Fosun Pharmaceutical Co., Ltd. Appoints Wen Deyong as an Executive Director	10/08/22	CI
Shanghai Fosun Pharmaceutical Co., Ltd. Announces Executive Appointments	01/06/22	CI
Shanghai Fosun Pharmaceutical Co., Ltd. Announces Board Changes	01/06/22	CI
Insilico Medicine Achieves Its First Major Milestone in Fosun Pharma Collaboration with the Nomination of Preclinical Candidate for QPCTL	17/02/22	CI
Shanghai Fosun Pharmaceutical Co., Ltd. Announces Board Appointments	07/12/21	CI
Shanghai Fosun Pharmaceutical Co., Ltd. Announces Board Changes	09/11/21	CI
Shanghai Fosun Pharmaceutical Co., Ltd. Announces Board Changes	11/06/21	CI
Shanghai Fosun Pharmaceutical Co., Ltd. Announces Retirement of Wong Tin Yau Kelvin as Independent Non-Executive Director	26/04/21	CI
Shanghai Fosun Pharmaceutical Co., Ltd. Announces Management Changes	29/10/20	CI
Shanghai Fosun Pharmaceutical Co., Ltd. Elects Zhang Houlin as Non-Executive Director	09/10/20	CI
Shanghai Fosun Pharmaceutical Co., Ltd. Announces Board Changes	30/06/20	CI
Shanghai Fosun Pharmaceutical Co., Ltd. Announces Establishment of Environmental, Social and Governance Committee	30/03/20	CI
Shanghai Fosun Pharmaceutical Co., Ltd. Announces Board and Committee Changes	21/01/20	CI
Liang Jianfeng Resigns as Non-Executive Director of Shanghai Fosun Pharmaceutical Co., Ltd	17/01/20	CI
Shanghai Fosun Pharmaceutical Co., Ltd. Announces Resignation Lo Yee Har, Susan as Joint Company Secretary	17/12/19	CI
Shanghai Fosun Pharmaceutical Co., Ltd. Announces Board Appointments	25/06/19	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Hong Kong S.E.

Equities

2196

CNE100001M79

Insiders

Filters